Cargando…
Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice
BACKGROUND: A variety of extra-intestinal manifestations (EIMs), including hepatobiliary complications, are associated with inflammatory bowel disease (IBD). Mesenchymal stem cells (MSCs) have been shown to play a potential role in the therapy of IBD. This study was designed to investigate the effec...
Autores principales: | Niu, Guo chao, Liu, Lei, Zheng, Libo, Zhang, Hong, Shih, David Q., Zhang, Xiaolan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090774/ https://www.ncbi.nlm.nih.gov/pubmed/30103680 http://dx.doi.org/10.1186/s12876-018-0850-7 |
Ejemplares similares
-
Toll-Like Receptors as Modulators of Mesenchymal Stem Cells
por: DelaRosa, Olga, et al.
Publicado: (2012) -
Fecal microbiota transplantation alleviates experimental colitis through the Toll-like receptor 4 signaling pathway
por: Wen, Xin, et al.
Publicado: (2023) -
Toll-like receptor triggering in cord blood mesenchymal stem cells
por: van den Berk, Lieke CJ, et al.
Publicado: (2009) -
Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis
por: FAN, YUJING, et al.
Publicado: (2015) -
Endoscopic Transplantation of Mesenchymal Stem Cell Sheets in Experimental Colitis in Rats
por: Pak, Sehyung, et al.
Publicado: (2018)